McGraw C, Ward C, Samaco R
Am J Med Genet C Semin Med Genet. 2017; 175(3):368-379.
PMID: 28910526
PMC: 5659732.
DOI: 10.1002/ajmg.c.31570.
Maubourguet N, Lesne A, Changeux J, Maskos U, Faure P
PLoS Comput Biol. 2008; 4(11):e1000229.
PMID: 19023420
PMC: 2581917.
DOI: 10.1371/journal.pcbi.1000229.
Hegadoren K, Martin-Iverson M, Baker G
Psychopharmacology (Berl). 1995; 118(3):295-304.
PMID: 7617822
DOI: 10.1007/BF02245958.
Winn P, Williams S, Herberg L
Psychopharmacology (Berl). 1982; 78(4):336-41.
PMID: 6818595
DOI: 10.1007/BF00433737.
Evenden J, Robbins T
Psychopharmacology (Berl). 1983; 80(1):67-73.
PMID: 6408674
DOI: 10.1007/BF00427498.
Chronic anorexic and behavioural effects of the fenfluramine metabolite, norfenfluramine: an evaluation of its role in the actions of fenfluramine.
Goudie A, Taylor M, Wheeler T
Psychopharmacologia. 1974; 38(1):67-74.
PMID: 4851021
DOI: 10.1007/BF00421288.
Intraspecies aggression in rats: effects of d-amphetamine and chlordiazepoxide.
Miczek K
Psychopharmacologia. 1974; 39(4):275-301.
PMID: 4476082
DOI: 10.1007/BF00422968.
Comparison between behaviours elicited by high doses of amphetamine and fenfluramine: implications for the concept of stereotypy.
Taylor M, Goudie A, Mortimore S, Wheeler T
Psychopharmacologia. 1974; 40(3):249-58.
PMID: 4475444
DOI: 10.1007/BF00429419.
Dopamine-sensitive alternation and collateral behaviour in a Y-maze: effects of d-amphetamine and haloperidol.
Oades R, Taghzouti K, Simon H, Le Moal M
Psychopharmacology (Berl). 1985; 85(1):123-8.
PMID: 3920694
DOI: 10.1007/BF00427335.
Use of activity measures in behavioral toxicology.
Reiter L
Environ Health Perspect. 1978; 26:9-20.
PMID: 363423
PMC: 1637245.
DOI: 10.1289/ehp.78269.
Plasma levels of d-amphetamine in hyperactive children. Serial behavior and motor responses.
Brown G, Hunt R, EBERT M, Bunney Jr W, Kopin I
Psychopharmacology (Berl). 1979; 62(2):133-40.
PMID: 111276
DOI: 10.1007/BF00427126.
